Downstream Processing Feasibility for Precision Fermentation Scale-Up

Optimizing and de-risking commercial scale-up of a yeast-based fermentation platform for high-value bio-based compounds.

The Opportunity

Canada imports more than $4B annually in natural health product, cosmetic, and specialty chemical ingredients. The precision fermentation market is projected to grow from $4B to $34.6B by 2030. Brain-health supplements alone are expected to reach $23.4B by 2030. REVO Bio Chem’s approach uses existing ethanol production infrastructure to reduce the capital intensity of domestic biomanufacturing, making the production of high-value bio-based compounds more cost-competitive and scalable.

The Challenge

REVO has validated strain performance and generated pilot data in an industrial setting. The next critical step is an engineering feasibility study for downstream processing that can support commercial scale-up and integration with existing ethanol facilities. Without this work, REVO cannot fully de-risk production economics, finalize scale-up assumptions, or raise the next round of private capital required to move the platform toward market.

NPC’s Solution

NPC’s Fast Track to Financing Program is supporting REVO Bio Chem with downstream processing feasibility and production planning to optimize and de-risk commercial scale-up. The project leverages REVO’s flexible, yeast-based fermentation platform, which utilizes existing ethanol production infrastructure to enable cost-effective production of high-value biocompounds for natural health products, flavours and fragrances, biofertilizers, and specialty chemicals. NPC is committed to the creation of natural products that are better for people, animals, and the planet. They propel early-stage Canadian innovators with the advice, connections, and capital needed to rapidly develop, validate, and scale transformative solutions.